Author

Jason D. Berger

Observed name: Jason Berger

Institution: Psychogenics (United States)

Observed institutions: Nathan Kline Institute for Psychiatric Research, Psychogenics (United States), New York University

OpenAlex ID: A5041925134

Age‐dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model

2009 · Jennifer H. K. Choi, Jason D. Berger, et al. · Journal of Neurochemistry · 83

In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the β-Amyloid Depositing Mice

2009 · Jose Morales-Corraliza, Matthew J. Mazzella, et al. · PLoS ONE · 59

Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD

2016 · Paul C. P. Curtin, Andrew M. Farrar, et al. · Frontiers in Behavioral Neuroscience · 50

Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington’s Disease

2013 · Stephen Oakeshott, Andrew Farrar, et al. · PLoS Currents · 35

Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model

2012 · Jose Morales-Corraliza, Stephen D. Schmidt, et al. · Neurobiology of Aging · 34

A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington’s disease

2012 · Stephen Oakeshott, Russell Port, et al. · PLoS Currents · 31

Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice

2011 · Jose Morales-Corraliza, Jason D. Berger, et al. · Neurobiology of Aging · 15

Temporal Control Deficits in Murine Models of Huntington’s Disease

2015 · Dani Brunner, Fuat Balcı, et al. · International Journal of Comparative Psychology · 5

O4‐06‐04: Immunization targeting a minor plaque constituent clears Aβ and rescues behavioral deficits in an Alzheimer's disease mouse model

2012 · Jose Morales‐Corraliza, Stephen Schmidt, et al. · Alzheimer s & Dementia · 1

P4‐039: Differences between TG2576‐ and APP/PS1 Mice in High‐Throughput Behavioral Screening Correlates with Differences in Brain Pathology

2016 · Taleen Hanania, Daniel Havas, et al. · Alzheimer s & Dementia

O4‐02‐05: In vivo turnover of tau and APP metabolites in the brains of wild‐type and Tg2576 mice: Greater stability of sAPP in the β‐amyloid‐depositing mice

2010 · Jose Morales-Corraliza, Matthew J. Mazzella, et al. · Alzheimer s & Dementia

P1‐079: Calpain inhibition by calpastatin overexpression reduces β‐amyloid deposition in an APP transgenic mouse

2008 · Jose Morales-Corraliza, Jason D. Berger, et al. · Alzheimer s & Dementia

P2–002: Levels and turnover of endogenous APP metabolites in the wild–type mouse brain

2006 · Matthew J. Mazzella, Nichole S. Diaz, et al. · Alzheimer s & Dementia

Works count: 14

Citation count: 313

H-index: 7

I10-index: 7